Cite
HARVARD Citation
Wallace, G. et al. (n.d.). NCMP-04. COMBINATION BRAF/MEK INHIBITION IMPROVES SURVIVAL WITH LEPTOMENINGEAL DISEASE FROM MELANOMA IN A SINGLE INSTITUTIONAL REVIEW AT MOFFITT CANCER CENTER. Neuro-oncology. p. vii191. [Online].